Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
46 hedge funds and large institutions have $25.9M invested in Applied Genetic Technologies Corporation in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 50 → 46 (-4)
16% less capital invested
Capital invested by funds: $30.8M → $25.9M (-$4.9M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
+$660K |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$385K |
| 3 |
Renaissance Technologies
New York
|
+$292K |
| 4 |
Squarepoint
New York
|
+$214K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$196K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.93M |
| 2 |
SIM
Spark Investment Management
New York
|
-$212K |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$210K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$192K |
| 5 |
Two Sigma Investments
New York
|
-$137K |
AGTC Hedge Fund Activity: Q2 2019 in Review
46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2019, worth a combined $25.9M — down 16% from $30.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AGTC and 4 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 14 added.
The largest buyer was Colony Group, opening a new position worth an estimated $660K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $2.93M sold.
- 46 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2019, down from 50 in Q1 2019.
- Funds reported $25.9M of Applied Genetic Technologies Corporation stock for Q2 2019, down 16% quarter-over-quarter.
- 4 funds opened new Applied Genetic Technologies Corporation positions in Q2 2019 and 6 closed out, a net change of -2 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2019 was Colony Group, an estimated $660K added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2019 was Acadian Asset Management, an estimated $2.93M sold.
Based on aggregated 13F filings for Q2 2019.